Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

بواسطة Hadji, Peyman
منشور في 2010

Cancer Treatment-Induced Bone Loss in women with breast cancer

بواسطة Hadji, Peyman
الحاوية / القاعدة Bonekey Rep (2015)

Prevention of bone metastases and management of bone health in early breast cancer

بواسطة Gnant, Michael, Hadji, Peyman
منشور في 2010

Correspondence (reply):In Reply

بواسطة Hadji, Peyman, Klein, Silvia
منشور في 2013

Breast Cancer and Osteoporosis – Management of Cancer Treatment-Induced Bone Loss in Postmenopausal Women with Breast Cancer

بواسطة Kalder, Matthias, Hadji, Peyman
الحاوية / القاعدة Breast Care (Basel) (2014)

Bone Oncology—An emerging multi-disciplinary specialty

بواسطة Coleman, Robert, Hadji, Peyman
الحاوية / القاعدة J Bone Oncol (2012)

JBO—Launched and flying ahead

بواسطة Coleman, Robert, Hadji, Peyman
الحاوية / القاعدة J Bone Oncol (2013)

Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case study

بواسطة Bryce, Jane, Bauer, Martina, Hadji, Peyman
منشور في 2012

Gender- and age-related treatment compliance in patients with osteoporosis in Germany

بواسطة Hadji, Peyman, Jacob, Louis, Kostev, Karel
الحاوية / القاعدة Patient Prefer Adherence (2016)

Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: Retrospective analysis results in an unselected single-center cohort

بواسطة Hadji, Peyman, Frank, Matthias, Jakob, Andreas, Siebers, Jan Willem
الحاوية / القاعدة J Bone Oncol (2013)

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

بواسطة Richter, Hartmut, Dombrowski, Silvia, Hamer, Hajo, Hadji, Peyman, Kostev, Karel
منشور في 2015-08-01

Physicians’ influence on breast cancer patient compliance

بواسطة Kostev, Karel, Waehlert, Lilia, Jockwig, Achim, Jockwig, Barbara, Hadji, Peyman
منشور في 2014

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

بواسطة Richter, Hartmut, Dombrowski, Silvia, Hamer, Hajo, Hadji, Peyman, Kostev, Karel
الحاوية / القاعدة Ger Med Sci (2015)

Incidence of fractures in young women with breast cancer - a retrospective cohort study

بواسطة Stumpf, Ulla, Kostev, Karel, Kyvernitakis, Iannis, Böcker, Wolfgang, Hadji, Peyman
الحاوية / القاعدة J Bone Oncol (2019)

Influence of chemotherapy and endocrine treatment on fractures in postmenopausal women with breast cancer – a retrospective cohort study

بواسطة Stumpf, Ulla, Kostev, Karel, Siebenbürger, Georg, Böcker, Wolfgang, Hadji, Peyman
الحاوية / القاعدة J Bone Oncol (2020)

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

بواسطة Ziller, Volker, Kyvernitakis, Ioannis, Knöll, Dana, Storch, Astrid, Hars, Olaf, Hadji, Peyman
منشور في 2013

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women

بواسطة Goss, Paul E, Hadji, Peyman, Subar, Milayna, Abreu, Paula, Thomsen, Torben, Banke-Bochita, Jose
منشور في 2007

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis

بواسطة Höer, Ariane, Seidlitz, Cornelia, Gothe, Holger, Schiffhorst, Guido, Olson, Melvin, Hadji, Peyman, Häussler, Bertram
منشور في 2009

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

بواسطة Waqas, Komal, Lima Ferreira, Joana, Tsourdi, Elena, Body, Jean-Jacques, Hadji, Peyman, Zillikens, M.C.
الحاوية / القاعدة J Bone Oncol (2021)

Regulation of VEGF by mevalonate pathway inhibition in breast cancer

بواسطة Rachner, Tilman D., Göbel, Andy, Junker, Maria, Hötzel, Josefa, Benad-Mehner, Peggy, Hadji, Peyman, Hofbauer, Lorenz C.
الحاوية / القاعدة J Bone Oncol (2013)